학술논문

Pathophysiology and pharmacology of G protein-coupled receptors in the heart.
Document Type
Article
Source
Cardiovascular Research. May2023, Vol. 119 Issue 5, p1117-1129. 13p.
Subject
*G protein coupled receptors
*CELL receptors
*ANGIOTENSIN receptors
*PHARMACOLOGY
*PATHOLOGICAL physiology
Language
ISSN
0008-6363
Abstract
G protein-coupled receptors (GPCRs), comprising the largest superfamily of cell surface receptors, serve as fundamental modulators of cardiac health and disease owing to their key roles in the regulation of heart rate, contractile dynamics, and cardiac function. Accordingly, GPCRs are heavily pursued as drug targets for a wide variety of cardiovascular diseases ranging from heart failure, cardiomyopathy, and arrhythmia to hypertension and coronary artery disease. Recent advancements in understanding the signalling mechanisms, regulation, and pharmacological properties of GPCRs have provided valuable insights that will guide the development of novel therapeutics. Herein, we review the cellular signalling mechanisms, pathophysiological roles, and pharmacological developments of the major GPCRs in the heart, highlighting the β-adrenergic, muscarinic, and angiotensin receptors as exemplar subfamilies. [ABSTRACT FROM AUTHOR]